athletes and very active individuals sometimes use up to 2,000 mg/day
Figure 1: A metabolic use-case comprehensive patient journey view with taXonomy Pathways In clinical trials, GLP-1 drugs showed high adherence (over 85% of patients stayed on therapy), yet real-world use tells a different story: one large study found only 32% of obese patients remained on a GLP-1 therapy after one year, with just 27% meeting standard adherence thresholds
Book online or speak with our team to find the right plan for you
Common early side effects include nausea, mild abdominal discomfort, and changes in bowel habits, which generally improve within 24 weeks as the body adjusts to the medication
Limiting high-fat, sugary foods also supports better blood sugar control
It accomplishes this by increasing natural growth hormone and sustaining the bodys own testosterone production